|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | C12N 15/09 | (2006.01) |
| C12N 15/13 | (2006.01) | ||
| G01N 33/50 | (2006.01) | ||
| A61K 39/395 | (2006.01) | ||
| C07K 16/00 | (2006.01) |
| (11) | Number of the document | 2164961 |
| (13) | Kind of document | T |
| (96) | European patent application number | 08757277.2 |
| Date of filing the European patent application | 2008-06-25 | |
| (97) | Date of publication of the European application | 2010-03-24 |
| (45) | Date of publication and mention of the grant of the patent | 2015-01-07 |
| (46) | Date of publication of the claims translation | 2015-04-27 |
| (86) | Number | PCT/CH2008/000284 |
| Date | 2008-06-25 |
| (87) | Number | WO 2009/000098 |
| Date | 2008-12-31 |
| (30) | Number | Date | Country code |
| 937112 P | 2007-06-25 | US | |
| 69057 P | 2008-03-12 | US |
| (72) |
BORRAS, Leonardo, CH
URECH, David, CH
|
| (73) |
Novartis AG ,
Lichtstrasse 35, 4056 Basel ,
CH
|
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
| (54) | Viengrandžių antikūnų inžinerija ir optimizavimas sekos pagrindu |
| SEQUENCE BASED ENGINEERING AND OPTIMIZATION OF SINGLE CHAIN ANTIBODIES |
| Payment date | Validity (years) | Amount | |
| 2025-05-22 | 18 | 347.00 EUR |
| 2026-06-25 |